Abstract
Background There has been no report on convergent local abnormalities of multiple functional brain imaging modalities including β-amyloid (Aβ) deposition, glucose metabolism, and resting-state functional magnetic resonance imaging (RS-fMRI) activities for participants with subjective cognitive decline (SCD).
Methods Fifty participants with SCD and 15 normal controls (NC) were scanned with both [18F]-florbetapir positron emission tomography (PET) and [18F]-fluorodeoxyglucose PET, each PET sacn accompanied with simultaneous RS-fMRI. Voxel-wise metrics were analyzed, including Aβ deposition, glucose metabolism, and three local metrics for RS-fMRI, i.e., amplitude of low frequency fluctuation (ALFF), regional homogeneity (ReHo), and degree centrality (DC).
Results The SCD group showed increased Aβ deposition and increased glucose metabolism (P < 0.05, corrected), as well as decreased ALFF, ReHo, and DC (P < 0.05, uncorrected) in the same area of the left dorsal precuneus (dPCu). The dPCu showed negative resting state functional connectivity (RSFC) with the default mode network (DMN). Regarding global Aβ deposition positivity, the Aβ deposition in the dPCu showed a gradient change, i.e., SCD+ > SCD- > NC-. Further, both SCD+ and SCD- showed increased glucose metabolism and decreased RS-fMRI metrics in the dPCu.
Conclusions The convergent abnormal activities in the dPCu of SCD indicate that the dPCu is an early vulnerable region. The anti-RSFC of the dPCu with DMN supports that the earliest symptoms might be more related to other cognitive functions (e.g., unfocused attention) than episodic memory. (Funded by the National Key Research and Development Program of China and others; ClinicalTrials.gov number, NCT03370744.)
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT03370744
Funding Statement
This work was supported by the National Natural Science Foundation of China (61633018, 82020108013 and 81661148045).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The ethics committee of Xuanwu Hospital of Capital Medical University.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The dataset generated and analyzed in the current study is available from the corresponding author on reasonable request.
